Millipore Sigma Vibrant Logo

AGX807 2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-7)

This E. coli recombinant protein , Cat. No. AGX807 is tested for use in and ELISA.

View Products on Sigmaaldrich.com
AGX807
1 mg  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
—
Solicitar precio
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information
      Description
      Catalogue NumberAGX807
      Description2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-7)
      Alternate Names
      • SARS-CoV
      • SARS-CoV-2
      Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 nucleocapsid antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
      References
      Product Information
      FormatPurified
      PresentationPurified protein in 25mM Tris-HCl with no preservatives, pH 8.0.
      Quality LevelMQ100
      Applications
      ApplicationThis E. coli recombinant protein , Cat. No. AGX807 is tested for use in and ELISA.
      Key Applications
      • ELISA
      Application NotesOther recommended antigen products for ELISA application are AGX805 or AGX809.
      Biological Information
      CloneN/A
      ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
      SpecificitySARS CoV-2
      Purification MethodColumn Purification
      UniProt Number
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
      Packaging Information
      Material Size1 mg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      AGX807 04061842457878

      Documentation

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-7) Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      2019-nCoV Nucleocapsid Recombinant Antigen,full length (Ag-7) Certificados de análisis

      CargoNúmero de lote
      2019-nCoV Nucleocaspid Recombinant Antigen,full length (Ag-7) - 3706645 3706645
      2019-nCoV Nucleocaspid Recombinant Antigen,full length (Ag-7) - 3810049 3810049
      2019-nCoV Nucleocaspid Recombinant Antigen,full length (Ag-7) - Q3471684 Q3471684